Differentiation of prostate cancer from benign prostatic hyperplasia (BPH) in the transitional zone by magnetic resonance spectroscopic imaging
10.3760/cma.j.issn.1671-7368.2010.10.021
- VernacularTitle:移行带前列腺癌与良性前列腺增生患者磁共振波谱的检测
- Author:
Saying LI
;
Min CHEN
;
Rui WANG
;
Wenchao WANG
;
Weifeng ZHAO
;
Cheng ZHOU
- Publication Type:Journal Article
- Keywords:
Prostatic neoplasms;
Magnetic resonance spectroscopy
- From:
Chinese Journal of General Practitioners
2010;09(10):718-720
- CountryChina
- Language:Chinese
-
Abstract:
Twenty patients with prostate cancer and 20 patients with benign prostate hyperplasia (BPH) in the transitional zone underwent magnetic resonance imaging (MRI) /magnetic resonance spectroscopic imaging ( MRSI ) examinations. The choline + creatine/citrate (CC/Ci) ratio and the choline/creatine (Cho/Cr) ratio were evaluated in each voxel with cancer or BPH confirmed by pathological results.Discriminant analysis was used to determine the power of the two ratios in differentiation between cancer and BPH. The CC/Ci ratio and Cho/Cr ratio for cancer voxels were significantly higher than those in the voxels with BPH in the transitional zone (CC/Ci: 2.26 ± 1.35 vs. 0.81 ±0.22, t =5.17, P <0. 01, Cho/Cr:4. 12 ± 1.65 vs. 1.25 ±0. 35, P<0. 01 ). As for the discriminant function with the CC/Cr ratio and the Cho/Cr ratio, the specificity, sensitivity, and accuracy were 99%, 86%, 93% respectively for the differentiation between cancer and BPH.